Evidence map›Paper›PMID 37351490›Full record

ArticleRoyal Society open science2023

Rapamycin supplementation of

Ewa Szlachcic, Maciej J Dańko, Marcin Czarnoleski

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Heat tolerance inPhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Article
  2. Rapamycin supplementation ofRoyal Society open science · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ewa SzlachcicLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Kraków, Poland.ORCID 0000-0002-4179-4068
Maciej J DańkoMax Planck Institute for Demographic Research, Rostock, Germany.ORCID 0000-0002-7924-9022
Marcin CzarnoleskiLife History Evolution Group, Institute of Environmental Sciences, Faculty of Biology, Jagiellonian University, Kraków, Poland.ORCID 0000-0003-2645-0360
Jagiellonian University · PLMax Planck Institute for Demographic Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intrinsic sources of mortality relate to the ability to meet the metabolic demands of tissue maintenance and repair, ultimately shaping ageing patterns. Anti-ageing mechanisms compete for resources with other functions, including those involved in maintaining functional plasma membranes. Consequently, organisms with smaller cells and more plasma membranes should devote more resources to membrane maintenance, leading to accelerated intrinsic mortality and ageing. To investigate this unexplored trade-off, we reared

Indexed as

ageingcell sizelife historymortalitysurvivorshipTOR

Identifiers

PMID37351490
PMCPMC10282583
OpenAlexW4381663529

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.